कंपनी का अवलोकन
Butterfly Network, Inc. operates within the healthcare sector, specifically focusing on the medical devices industry, where it develops, manufactures, and commercializes advanced ultrasound imaging solutions for both domestic and international markets. The firm's core offering includes the Butterfly iQ+ and iQ3 ultrasound devices, which are engineered to perform comprehensive whole-body imaging using a single handheld probe that integrates seamlessly into existing clinical workflows. This specialized business model positions the company as a provider of innovative diagnostic technology aimed at enhancing accessibility and efficiency in medical imaging procedures. As of the latest reporting period, the entity maintains a market capitalization of $1.06 billion and employs a workforce of 220 individuals to support its operations and commercialization efforts. The reported annual revenue of $97.61 million over the trailing twelve months reflects the company's current operational scale, indicating that while it has achieved significant growth, its financial size remains relatively modest compared to large-cap medical device conglomerates. These valuation and revenue figures suggest that the market views the company as a high-growth, early-to-mid-stage enterprise that relies heavily on future expansion rather than established cash flow dominance to justify its market value.
वित्तीय स्वास्थ्य
The company reported a trailing twelve-month revenue of $97.61 million, yet it simultaneously recorded a net income loss of $77.064 million and an EBITDA of -$54.158 million, revealing a substantial gap between top-line sales and profitability that highlights a challenging cost structure. This significant divergence indicates that operating expenses and costs of goods sold are consuming a disproportionate amount of revenue, resulting in a net profit margin of -79.0% and an operating margin of -36.1%. Despite these accounting losses, the company generated positive free cash flow of $12.72 million, which suggests a degree of financial flexibility derived from efficient working capital management or non-cash charges that allow for operational continuity without immediate external financing. The balance sheet shows a robust liquidity position with $150.49 million in cash reserves against a total debt load of $20.40 million, creating a conservative debt-to-equity ratio of 10.41 that mitigates refinancing risk in the short term. Furthermore, the current ratio stands at 3.83, indicating that the company holds nearly four times the current assets necessary to cover its short-term liabilities, which points to strong short-term solvency. However, the return on equity is -42.2% and the return on assets is -13.2%, metrics that collectively reveal that management has yet to generate returns sufficient to reward shareholders or enhance the efficiency of the asset base, a common characteristic for pre-profitability technology firms.
मूल्यांकन आकलन
The valuation metrics for Butterfly Network, Inc. present a complex picture, with a trailing twelve-month P/E ratio listed as N/A due to negative earnings, while the forward P/E is reported at -41.50, implying that the market prices in significant future earnings growth to overcome current losses. The price-to-book ratio is calculated at 5.38, indicating that the market values the company at more than five times its net book value, which suggests a high premium assigned to its intangible assets, such as proprietary ultrasound technology and intellectual property. Alternative valuation measures like the price-to-sales ratio of 10.83 and the enterprise value to EBITDA of -17.11 further highlight that the stock is priced based on revenue multiples rather than earnings, a typical approach for high-growth companies that have not yet achieved profitability. The stock's trading range over the last year spans from a low of $1.32 to a high of $5.03, providing a context for the current valuation multiple relative to historical volatility. With a beta of 2.22, the stock exhibits price volatility that is more than twice that of the broader market, meaning that price movements are highly sensitive to general market shifts and investor sentiment regarding the medical device sector. These high multiple valuations combined with a negative forward P/E suggest that the market is betting heavily on the company's ability to turn profitable quickly to justify the current equity price.
Growth & Income
Butterfly Network, Inc. demonstrated robust top-line expansion with revenue growth of 41.0% year-over-year, while earnings growth is listed as N/A due to the company's continued losses. This disparity, where revenue is growing rapidly but earnings remain negative, implies that the company is prioritizing market share capture and product adoption over immediate profitability, a strategy often seen in capital-intensive medical device development. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which confirms that all available earnings and cash reserves are being reinvested back into the business to fund research, development, and commercialization of new ultrasound technologies. Consequently, the overall growth and income profile is characterized by aggressive revenue expansion funded by internal cash generation and existing cash reserves rather than shareholder distributions. This reinvestment strategy is essential for sustaining the 41.0% revenue growth trajectory and for eventually reaching the profitability threshold required to support a dividend or reduce the negative return metrics currently observed.